These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 35831519)

  • 1. Patient-Derived Sarcoma Organoids Offer a Novel Platform for Personalized Precision Medicine.
    Sanchez-Fdez A; Sharma AK; Tiriac H; Sicklick JK
    Ann Surg Oncol; 2022 Nov; 29(12):7239-7241. PubMed ID: 35831519
    [No Abstract]   [Full Text] [Related]  

  • 2. Epithelioid sarcoma as the prototype for personalized therapy in soft tissue sarcoma.
    Assi T; Rassy E; Nassereddine H; Farhat F; Kattan J
    Per Med; 2020 Jul; 17(4):241-244. PubMed ID: 32589100
    [No Abstract]   [Full Text] [Related]  

  • 3. Soft-tissue sarcoma in adults: An update on the current state of histiotype-specific management in an era of personalized medicine.
    Gamboa AC; Gronchi A; Cardona K
    CA Cancer J Clin; 2020 May; 70(3):200-229. PubMed ID: 32275330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organoids: A New Chapter in Sarcoma Diagnosis and Treatment.
    Psilopatis I; Kokkali S; Palamaris K; Digklia A; Vrettou K; Theocharis S
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-Specific Sarcoma Organoids for Personalized Translational Research: Unification of the Operating Room with Rare Cancer Research and Clinical Implications.
    Forsythe SD; Sivakumar H; Erali RA; Wajih N; Li W; Shen P; Levine EA; Miller KE; Skardal A; Votanopoulos KI
    Ann Surg Oncol; 2022 Nov; 29(12):7354-7367. PubMed ID: 35780216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-Related Quality of Life in Patients With Sarcoma: Enhancing Personalized Medicine.
    Younger E; Wilson R; van der Graaf WTA; Husson O
    J Clin Oncol; 2018 Jun; 36(16):1642-1643. PubMed ID: 29668370
    [No Abstract]   [Full Text] [Related]  

  • 7. Editorial: precision medicine of sarcomas and aggressive connective tissue tumours: from one-size-fits-all to haute couture.
    Blay JY
    Curr Opin Oncol; 2022 Jul; 34(4):320-321. PubMed ID: 35837702
    [No Abstract]   [Full Text] [Related]  

  • 8. Phase II study of personalized peptide vaccination for refractory bone and soft tissue sarcoma patients.
    Takahashi R; Ishibashi Y; Hiraoka K; Matsueda S; Kawano K; Kawahara A; Kage M; Ohshima K; Yamanaka R; Shichijo S; Shirouzu K; Itoh K; Sasada T
    Cancer Sci; 2013 Oct; 104(10):1285-94. PubMed ID: 23829867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Road Map for Precision Cancer Medicine Using Personalized Models.
    Picco G; Garnett MJ
    Cancer Discov; 2017 May; 7(5):456-458. PubMed ID: 28461408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fusion gene-oriented precision medicine in soft tissue sarcoma.
    Araki N
    Lancet Oncol; 2019 Sep; 20(9):1189-1190. PubMed ID: 31331698
    [No Abstract]   [Full Text] [Related]  

  • 11. Liver organoids: a promising three-dimensional model for insights and innovations in tumor progression and precision medicine of liver cancer.
    Chen Y; Liu Y; Chen S; Zhang L; Rao J; Lu X; Ma Y
    Front Immunol; 2023; 14():1180184. PubMed ID: 37334366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ASO Author Reflections: Sarcoma Organoids: Neutralizing the Word "Rare" in Rare Cancers.
    Forsythe SD; Sivakumar H; Erali RA; Skardal A; Votanopoulos KI
    Ann Surg Oncol; 2022 Nov; 29(12):7368-7369. PubMed ID: 35778628
    [No Abstract]   [Full Text] [Related]  

  • 13. Immune organoids: from tumor modeling to precision oncology.
    Dao V; Yuki K; Lo YH; Nakano M; Kuo CJ
    Trends Cancer; 2022 Oct; 8(10):870-880. PubMed ID: 35773148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical investigation of patient-derived cervical cancer organoids for precision medicine.
    Seol HS; Oh JH; Choi E; Kim S; Kim H; Nam EJ
    J Gynecol Oncol; 2023 May; 34(3):e35. PubMed ID: 36659831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient-derived organoids as a preclinical platform for precision medicine in colorectal cancer.
    Cho YW; Min DW; Kim HP; An Y; Kim S; Youk J; Chun J; Im JP; Song SH; Ju YS; Han SW; Park KJ; Kim TY
    Mol Oncol; 2022 Jun; 16(12):2396-2412. PubMed ID: 34850547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organoids for Drug Discovery and Personalized Medicine.
    Takahashi T
    Annu Rev Pharmacol Toxicol; 2019 Jan; 59():447-462. PubMed ID: 30113875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastatic soft tissue sarcoma chemotherapy: an opportunity for personalized medicine.
    Reed D; Altiok S
    Cancer Control; 2011 Jul; 18(3):188-95. PubMed ID: 21666581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-derived tumor organoids as a platform of precision treatment for malignant brain tumors.
    Chen CC; Li HW; Wang YL; Lee CC; Shen YC; Hsieh CY; Lin HL; Chen XX; Cho DY; Hsieh CL; Guo JH; Wei ST; Wang J; Wang SC
    Sci Rep; 2022 Sep; 12(1):16399. PubMed ID: 36180511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soft tissue sarcoma nomograms and their incorporation into practice.
    Callegaro D; Miceli R; Mariani L; Raut CP; Gronchi A
    Cancer; 2017 Aug; 123(15):2802-2820. PubMed ID: 28493287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personalized
    Pauli C; Hopkins BD; Prandi D; Shaw R; Fedrizzi T; Sboner A; Sailer V; Augello M; Puca L; Rosati R; McNary TJ; Churakova Y; Cheung C; Triscott J; Pisapia D; Rao R; Mosquera JM; Robinson B; Faltas BM; Emerling BE; Gadi VK; Bernard B; Elemento O; Beltran H; Demichelis F; Kemp CJ; Grandori C; Cantley LC; Rubin MA
    Cancer Discov; 2017 May; 7(5):462-477. PubMed ID: 28331002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.